← Back to All Filings

New Director Appointment: Kevin Lobo Joins GE HealthCare Board

Low SignificanceMarch 17, 2026 at 4:07:26 PM EDT

GE HealthCare Technologies Inc.

$GEHC3CIK: 0001932393

Subscribe to track GEHC

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

New Director Appointment: Kevin Lobo Joins GE HealthCare Board

Company: GE HealthCare Technologies Inc. (GEHC) Form: 3 (Initial Statement) | Filed: 2026/03/17 Significance: Low

Insider: Lobo Kevin Relationship: Director

Transaction Details: • Type: Initial Filing (New Insider) • Holdings Reported: 0 shares • Value: $0

Key Insight: Kevin Lobo has filed an initial statement of beneficial ownership upon becoming a Director. The filing indicates no securities are currently beneficially owned.

Market Context: GEHC has a market cap of $32.25B. This is a standard governance filing with no immediate trading impact.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: GE HealthCare Technologies Inc. (GEHC)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Kevin Lobo files initial Form 3 as a new Director, reporting zero initial share ownership.
  • Market Impact: Neutral - Standard corporate governance procedure.

Company Information

FieldValue
CompanyGE HealthCare Technologies Inc.
Ticker SymbolGEHC
CIK0001932393
IndustryMedical Devices

Insider Information

FieldValue
NameLobo Kevin
CIK0001519419
Title/PositionN/A (Director)
RelationshipDirector

Transaction Details

FieldValue
Form Type3 (Initial Statement)
Transaction Date2026-03-13
Transaction CodeN/A
Security TypeN/A
Shares Involved0
Price Per ShareN/A
Total Value$0
Shares Owned After0
Ownership TypeN/A

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.00%
Shares Transacted0
% of Shares Outstanding0.00%
Post-Transaction Ownership0 shares (0.00% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market capitalization of $32.25 billion, this filing represents a procedural update regarding board composition rather than a capital transaction.
  • Ownership Concentration: The insider currently holds no equity position in the company.
  • Dilution Impact: None.
  • Transaction Significance: This is a Form 3 filing which marks the initial reporting of a new insider. The specific flag <noSecuritiesOwned>1</noSecuritiesOwned> in the filing confirms the director enters the role with no pre-existing position.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: No shares were bought or sold. This filing purely establishes a reporting relationship for a new director.

Volume & Sentiment

  • Expected Volume Impact: None.
  • Sentiment Indicator: Neutral. While adding a new director can be strategically positive depending on the individual's background, this specific filing contains no transactional data to drive sentiment.

Additional Context

Transaction Notes

  • Timing: Filed on 2026/03/17 regarding an event on 2026-03-13.
  • Special Circumstances: The filing includes a Power of Attorney (Exhibit 24.1), authorizing Frank R. Jimenez and Jenny L. Lauth to sign future filings on Mr. Lobo's behalf.
Topics:#GEHC#GEHealthCare#Form3#DirectorAppointment#CorporateGovernance#MedTech#StockMarket#FinancialNews

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.